Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892. (Q44812238)
Jump to navigation
Jump to search
scientific article published in April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892. |
scientific article published in April 2004 |
Statements
1 reference
Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892. (English)
1 reference
Michele Pavone-Macaluso
1 reference
Fritz H Schröder
1 reference
Theo M de Reijke
1 reference
Laurence Collette
1 reference
Peter Whelan
1 reference
Karl Heinz Kurth
1 reference
Johan Mattelaer
1 reference
Roland F van Velthoven
1 reference
Muriel Debois
1 reference
Members of the EORTC Genito-Urinary Group
1 reference
1 April 2004
1 reference
1 reference
45
1 reference
4
1 reference
457-464
1 reference
Identifiers
1 reference
1 reference